Case series of first 3 monkeypox patients in Massachusetts treated with tecoviromat

A team of US-based scientists has described the therapeutic efficacy of a pan-Orthopoxvirus inhibitor, tecovirimat, in patients with monkeypox infection

Related Keywords

Central African Republic ,United States ,Ankara ,Turkey ,United Kingdom ,Massachusetts ,Central African ,Berkay Ataseven Shutterstock ,Forum Infectious Diseases ,Drug Administration ,Open Forum Infectious Diseases ,Image Credit ,West Africa ,West African ,Monkeypox ,Efficacy ,Fever ,Shiv ,Hospital ,Immunity ,Infectious Diseases ,Penis ,Prophylaxis ,Skin ,Smallpox ,Swallowing ,Virus ,